AAA
OKUR

Affinity Asset Advisors’s OnKure Therapeutics OKUR Stock Holding History

Affinity Asset Advisors’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Hold
240,963
– – 0.05% 104
2026
Q1 		$998K Buy
+240,963
New +$744K 0.05% 100
2025
Q3 		– Sell
-347,990
Closed -$832K – 114
2025
Q2 		$832K Sell
347,990
-46,169
-12% -$121K 0.11% 71
2025
Q1 		$1.69M Buy
394,159
+250,000
+173% +$1.41M 0.16% 70
2024
Q4 		$1.24M Buy
+144,159
New +$2.18M 0.17% 67

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Affinity Asset Advisors's OKUR Position: Q2 2026 in Review

Affinity Asset Advisors held its OnKure Therapeutics (OKUR) position steady in Q2 2026 at 240,963 shares worth $1.1M. The position accounts for 0.05% of the portfolio, ranked #104.

Affinity Asset Advisors first reported a position in OKUR in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.69M in Q1 2025. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Affinity Asset Advisors held 240,963 shares of OnKure Therapeutics worth $1.1M as of Q2 2026.
  • Affinity Asset Advisors left its OnKure Therapeutics share count unchanged in Q2 2026.
  • OnKure Therapeutics made up 0.05% of Affinity Asset Advisors's portfolio in Q2 2026, its #104 holding.
  • Affinity Asset Advisors first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Affinity Asset Advisors's OnKure Therapeutics position peaked at $1.69M in Q1 2025.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.